The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
100 reports and counting
Eikon Therapeutics raises $106M Series C at $1B valuation
Eikon Therapeutics raises $106M in Series C at $1B valuation. Biotech startup developing cancer-fighting therapeutic assets...
Eikon Therapeutics raises $350.7M Series D at $3B valuation
Eikon Therapeutics raises $350.7M in Series D at $3B valuation. Drug discovery using advanced microscopy...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Kailera Therapeutics raises $400M Series A at $1.5B valuation
Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...
Expedition Therapeutics raises $165M Series B at $850M valuation
Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...
Candid Therapeutics raises $370M Series A at $1.2B valuation
Candid Therapeutics raises $370M in Series A at $1.2B valuation. Developing novel therapeutics for autoimmune diseases...
Tune Therapeutics raises $175M Growth
Tune Therapeutics raises $175M in Growth. Epigenetic programming startup developing therapies for chronic conditions...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.